Atala Financial’s Microbot Medical MBOT Stock Holding History

Atala Financial’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$3	–	316
2025 Q1	$3	Hold	2	–	–	﹤0.01%	472
2024 Q4	$2	Buy	+2	New	+$2	﹤0.01%	475

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Atala Financial's MBOT Position: Q2 2025 in Review

Atala Financial sold out of Microbot Medical (MBOT) in Q2 2025, closing a stake of 2 shares — an estimated $3 sold.

Atala Financial first reported a position in MBOT in Q4 2024 and held it in 2 quarters. The position peaked at $3 in Q1 2025. 49 funds tracked by Wall St. Rank hold MBOT as of Q2 2025.

Atala Financial reported no remaining Microbot Medical position as of Q2 2025 after selling out during the quarter.
Atala Financial sold 2 Microbot Medical shares in Q2 2025, an estimated $3.
Atala Financial first reported a position in Microbot Medical in Q4 2024 and held it in 2 quarters.
Atala Financial's Microbot Medical position peaked at $3 in Q1 2025.
49 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2025.

Based on Atala Financial's 13F filing for Q2 2025, filed 7 Aug 2025.